About: FDA may allow drug and device companies to promote “off-label” uses

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : FDA may allow drug and device companies to promote “off-label” uses Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/bmj/2007/volume_335/issue_7632/w
Subject	Drugs: cardiovascular system Postgraduate Drugs: psychiatry Medicines regulation news Journalology Continuous professional development Drugs: musculoskeletal and joint diseases Medical humanities
Title	FDA may allow drug and device companies to promote “off-label” uses
has manifestation of work	http://hub.abes.fr/bmj/periodical/bmj/2007/volume_335/issue_7632/B36E2DCCDA882CFCE053120B220AC69C/m/web http://hub.abes.fr/bmj/periodical/bmj/2007/volume_335/issue_7632/B36E2DCCDA882CFCE053120B220AC69C/m/print
related by	http://hub.abes.fr/bmj/periodical/bmj/2007/volume_335/issue_7632/B36E2DCCDA882CFCE053120B220AC69C/authorship/1
article type	news
publisher identifier	fda1512
is part of this journal	British Medical Journal
PubMed ID	18079531

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata